Clinical Trial Update: Study of HD Mesh Ablation System for Treatment of Paroxysmal Atrial Fibrillation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Bard's HD Mesh Ablation System for paroxysmal atrial fibrillation was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Atrial Fibrillation

Drugs mentioned

• HD Mesh Ablation System

Snippet

Sponsor: C. R. Bard | Conditions: Paroxysmal Atrial Fibrillation | Phase 3 | Status: TERMINATED | Results posted: 2012-10-26